Dr. Gregory Glover

Council Member Biography

Greg Glover is Principal at Pharmaceutical Law Group in Washington, DC, where his practice focuses on providing advice on the strategic interaction of Food and Drug Administration (FDA) regulations, intellectual property law, and technology licensing. Dr. Glover has represented the research-based pharmaceutical trade association on market exclusivity strategies and domestic IP issues, and he has particular expertise in the patent and non-patent market exclusivity provisions of the Drug Price Competition and Patent Term Restoration Act of 1984 (the Hatch-Waxman Act). Previously, he was Partner at Ropes & Gray and was co-coordinator of the firm's Life Sciences Practice Group. Dr. Glover has also published articles on topics, such as the IP implications of patent and non-patent market exclusivity, the effect of the patent infringement exemption on biotechnology products, developing trends in the regulation of biologics, the implementation of antitrust scrutiny for IP rights, and emerging (This is me - Update Profile)

Employment History

2006 - Unspecified

Partner, Pharmaceutical Law Group PC

1999 - 1999

Partner, ROPES & GRAY LLP